Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schraml

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Plos One|November 19, 2021
Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneityAnna Fomitcheva-Khartchenko, Maria Anna Rapsomaniki, Bettina Sobottka, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinomaAdriana von Teichman, Eva Compérat, Silvia Behnke, et al.
Oncotarget|January 5, 2017
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinomaCaroline Fanja Razafinjatovo, Daniel Stiehl, Eva Deininger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2023
Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct EntityAashil A Batavia, Dorothea Rutishauser, Bettina Sobottka, et al.
BMC Genomics|April 19, 2015
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancerDorothee Pflueger, Christiane Mittmann, Silvia Dehler, et al.
Plos One|May 12, 2017
Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sectionsJulien F Cors, Aditya Kashyap, Anna Fomitcheva Khartchenko, et al.
International Journal of Cancer|September 6, 2012
Loss of PBRM1 expression is associated with renal cell carcinoma progressionRafal Pawłowski, Sarah M Mühl, Tullio Sulser, et al.
Nature Communications|May 3, 2012
Reliable detection of subclonal single-nucleotide variants in tumour cell populationsMoritz Gerstung, Christian Beisel, Markus Rechsteiner, et al.
BMC Cancer|August 18, 2016
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevanceCaroline Razafinjatovo, Svenja Bihr, Axel Mischo, et al.
Cancer Research|March 5, 2004
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinomaKirsten Struckmann, Peter Schraml, Ronald Simon, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Plos One|November 19, 2021
Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneityAnna Fomitcheva-Khartchenko, Maria Anna Rapsomaniki, Bettina Sobottka, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinomaAdriana von Teichman, Eva Compérat, Silvia Behnke, et al.
Oncotarget|January 5, 2017
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinomaCaroline Fanja Razafinjatovo, Daniel Stiehl, Eva Deininger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 23, 2023
Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct EntityAashil A Batavia, Dorothea Rutishauser, Bettina Sobottka, et al.
BMC Genomics|April 19, 2015
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancerDorothee Pflueger, Christiane Mittmann, Silvia Dehler, et al.
Plos One|May 12, 2017
Tissue lithography: Microscale dewaxing to enable retrospective studies on formalin-fixed paraffin-embedded (FFPE) tissue sectionsJulien F Cors, Aditya Kashyap, Anna Fomitcheva Khartchenko, et al.
International Journal of Cancer|September 6, 2012
Loss of PBRM1 expression is associated with renal cell carcinoma progressionRafal Pawłowski, Sarah M Mühl, Tullio Sulser, et al.
Nature Communications|May 3, 2012
Reliable detection of subclonal single-nucleotide variants in tumour cell populationsMoritz Gerstung, Christian Beisel, Markus Rechsteiner, et al.
BMC Cancer|August 18, 2016
Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevanceCaroline Razafinjatovo, Svenja Bihr, Axel Mischo, et al.
Cancer Research|March 5, 2004
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinomaKirsten Struckmann, Peter Schraml, Ronald Simon, et al.
Pageof 12